GE Healthcare to invest $1 billion in oncology solutions
GE Healthcare to invest $1 billion in oncology solutions

GE Healthcare, the health business of General Electric, announced its plans to dedicate $1billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging capabilities, as well as its world-class technologies for the manufacture of biopharmaceuticals and for cancer research.

whatsapp--v1